ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
10,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
10,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
13,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
16,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
16,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
16,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
16,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
17,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
17,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
17,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
18,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
18,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
18,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
18,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
19,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
19,2,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
20,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
20,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
20,3,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
20,4,Hepatic haematoma,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
20,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
20,6,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
21,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
22,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
23,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
23,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
24,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
25,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
25,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
26,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
28,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
28,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
29,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
29,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
29,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
29,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
29,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
29,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,1,Eye infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
31,3,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
32,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
33,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
33,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
33,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
33,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
33,5,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
35,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
35,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
35,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
36,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
37,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
38,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
39,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
40,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
40,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
41,1,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
41,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
41,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,4,Poikilocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
41,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
41,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
44,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
45,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
45,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
46,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
48,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
48,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
51,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
52,1,Complications of transplant surgery,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
52,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
53,1,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
54,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
54,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
56,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
57,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
59,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
60,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
60,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
61,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
62,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
63,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
64,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
65,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
65,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
65,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,4,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
69,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
69,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
71,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
72,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
73,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
74,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
75,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
75,2,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
75,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
75,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,5,Immune recovery uveitis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,6,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
75,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
75,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
75,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
75,10,Polymerase chain reaction positive,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
75,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
75,13,Vitreous opacities,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
75,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
76,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
76,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
77,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
77,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
77,3,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
77,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
77,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,6,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
77,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
77,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
77,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
78,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Incorrect product dosage form administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
80,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
80,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
81,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
82,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
83,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
84,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
85,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
85,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
85,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
85,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
85,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
86,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
86,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
86,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
87,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
87,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
88,1,Carnitine deficiency,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
88,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
88,3,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
92,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
93,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
94,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
94,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
94,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
94,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
94,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
94,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
95,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
95,2,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
95,3,Headache,Headaches NEC,Headaches,Nerv,N
95,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
96,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
96,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
96,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
97,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
97,2,Myocarditis toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
97,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
98,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
98,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
98,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
98,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
98,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
98,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
98,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
98,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
98,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
98,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
98,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
99,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
100,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
101,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
102,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
102,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
104,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
105,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
105,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
106,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
106,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
108,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
108,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
109,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
109,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
110,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
112,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
112,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
112,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
113,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
113,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
113,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,4,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
114,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
115,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
116,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
117,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
118,1,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
118,2,Tendon discomfort,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
119,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
120,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
123,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
124,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
125,1,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
125,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
126,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
127,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
128,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
129,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
131,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
132,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
134,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
135,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
135,3,Cerebellar hypoplasia,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
135,4,Congenital cytomegalovirus infection,Viral infections congenital,Infections and infestations congenital,Cong,N
135,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
135,6,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
135,7,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
135,8,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
136,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
138,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
139,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
141,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
141,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
141,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
141,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
141,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
141,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
141,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
141,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
141,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
141,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
142,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
143,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
144,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
145,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
145,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
147,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
148,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
149,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
150,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
151,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
154,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
155,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
156,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
156,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
